These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 26692196)
1. Human bone marrow mesenchymal stromal/stem cells: current clinical applications and potential for hematology. Miura Y Int J Hematol; 2016 Feb; 103(2):122-8. PubMed ID: 26692196 [TBL] [Abstract][Full Text] [Related]
2. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation. Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866 [TBL] [Abstract][Full Text] [Related]
3. Mesenchymal Stromal Cell Therapy in Hematology: From Laboratory to Clinic and Back Again. De Becker A; Van Riet I Stem Cells Dev; 2015 Aug; 24(15):1713-29. PubMed ID: 25923433 [TBL] [Abstract][Full Text] [Related]
4. [Current basic understanding and clinical application of mesenchymal stromal/stem cells]. Miura Y Rinsho Ketsueki; 2018; 59(10):1935-1941. PubMed ID: 30305494 [TBL] [Abstract][Full Text] [Related]
5. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model. Li ZY; Wang CQ; Lu G; Pan XY; Xu KL Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072 [TBL] [Abstract][Full Text] [Related]
12. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model. Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894 [TBL] [Abstract][Full Text] [Related]
13. [Research progress on immunologic mechanisms of mesenchymal stem cells for treatment of graft-versus-host disease]. Wang RP; Chen H; Guo YQ; Wu RN; Zhang B Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):550-3. PubMed ID: 21518528 [TBL] [Abstract][Full Text] [Related]
14. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models. Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502 [TBL] [Abstract][Full Text] [Related]
15. [Clinical application of mesenchymal stem cells for hematological diseases]. Taketani T Rinsho Ketsueki; 2018; 59(10):2362-2372. PubMed ID: 30305547 [TBL] [Abstract][Full Text] [Related]
16. Insurance approval of mesenchymal stem cell for acute GVHD in Japan: need of follow up for some remaining concerns. Miyamura K Int J Hematol; 2016 Feb; 103(2):155-64. PubMed ID: 26759322 [TBL] [Abstract][Full Text] [Related]
17. The immunosuppressive properties of non-cultured dermal-derived mesenchymal stromal cells and the control of graft-versus-host disease. Gao L; Liu F; Tan L; Liu T; Chen Z; Shi C Biomaterials; 2014 Apr; 35(11):3582-8. PubMed ID: 24468404 [TBL] [Abstract][Full Text] [Related]
18. [The use of mesenchymal stromal cells in oncology and cell therapy]. Pommey S; Galipeau J Bull Cancer; 2006 Sep; 93(9):901-7. PubMed ID: 16980233 [TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stromal cells for cell therapy: besides supporting hematopoiesis. Hao L; Sun H; Wang J; Wang T; Wang M; Zou Z Int J Hematol; 2012 Jan; 95(1):34-46. PubMed ID: 22183780 [TBL] [Abstract][Full Text] [Related]
20. [Basics and clinical application of human mesenchymal stromal/stem cells]. Miura Y Rinsho Ketsueki; 2015 Oct; 56(10):2195-204. PubMed ID: 26458460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]